Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety
- 4 September 2012
- journal article
- research article
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 13 (9), 745-750
- https://doi.org/10.1631/jzus.b1200120
Abstract
To evaluate the clinical effect of topical imiquimod treatment on cutaneous vascular disorders in pediatric patients. A retrospective investigation was conducted in 25 pediatric patients with cutaneous vascular disorders, including 19 infantile hemangiomas (IHs) (12 superficial/7 mixed type), 5 nevus flammeus (NF), and 1 pyogenic granuloma (PG). Imiquimod 5% cream was applied every other day for 4 to 16 weeks (average 9.6 weeks). Of the 19 IHs treated, an overall efficacy of 52.6% was achieved, with a clinical resolution rate of 15.8%, excellent rate of 26.3%, and moderate rate of 10.5%. The superficial type responded the best at 66.7%, while the mixed type showed only 28.6% effectiveness, which was predominantly from their superficial parts. No obvious response was noted in the 5 patients with NF. Side effects were observed in 78.9% of the patients, mostly mild to moderate local irritations and occasionally severe reactions such as thick crusting and ulceration. Systemic side events were observed in 4 IH patients including fever and digestive tract reactions. No recurrence was observed during the follow-up examination. Topical imiquimod could be an alternative option for the treatment of uncomplicated superficial IHs with satisfactory tolerability.Keywords
This publication has 20 references indexed in Scilit:
- A Phase II, Open‐Label Study of the Efficacy and Safety of Imiquimod in the Treatment of Superficial and Mixed Infantile HemangiomaPediatric Dermatology, 2009
- Involution of infantile haemangiomas after imiquimod 5% creamClinical and Experimental Dermatology, 2008
- Immune response: A possible role in the pathophysiology of hemangiomaMedical Hypotheses, 2007
- Topical imiquimod in the treatment of infantile hemangiomas: A retrospective studyJournal of the American Academy of Dermatology, 2007
- Infantile hemangiomasJournal of the American Academy of Dermatology, 2006
- Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary diseaseJournal of the American Academy of Dermatology, 2006
- Proliferating Hemangioma of Infancy: Successful Treatment with Topical 5% Imiquimod CreamPediatric Dermatology, 2005
- Treatment of infantile hemangiomas with short-term application of imiquimod 5% creamJournal of the American Academy of Dermatology, 2004
- Topically Applied Imiquimod Inhibits Vascular Tumor Growth In VivoJournal of Investigative Dermatology, 2003
- Inhibition of Cell Motility by InterferonScience, 1980